SCHEMBL2881499

SCHEMBL2881499

[CH2][C@H]1C[C@@H](N(C)c2ncnc3c2nc(-c2ccccc2)n3C)C[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NAE1 Q13564 1/20 0.66
UBA3 Q8TBC4 1/20 0.66
ADORA3 P0DMS8 15/20 0.48
ADORA1 P30542 15/20 0.48
ADORA2A P29274 14/20 0.48
ADORA2B P29275 8/20 0.48
PI4KA P42356 1/20 0.48
PI4K2B Q8TCG2 1/20 0.48
PI4K2A Q9BTU6 1/20 0.48
PI4KB Q9UBF8 1/20 0.48
LMNA P02545 1/20 0.36
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36
CDK2 P24941 1/20 0.36
PLK1 P53350 1/20 0.36
BTK Q06187 1/20 0.36
ITK Q08881 1/20 0.36
IKBKE Q14164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881503 0.90 NAE1 (0.66) NAE1UBA3ADORA3ADORA1ADORA2A
SCHEMBL15007809 0.83 NAE1 (0.59) NAE1UBA3ADORA3ADORA1ADORA2A
SCHEMBL782859 0.80 NAE1 (1.00) NAE1UBA3ADORA3ADORA1ADORA2A
SCHEMBL15007419 0.77 ADORA3 (0.68) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL782836 0.72 NAE1 (0.57) NAE1UBA3ADORA3ADORA1ADORA2A
SCHEMBL805388 0.72 NAE1 (0.73) NAE1UBA3ADORA3ADORA1ADORA2A
SCHEMBL8655787 0.69 ADORA3 (0.68) NAE1UBA3ADORA3ADORA1ADORA2A
SCHEMBL15007420 0.67 ADORA3 (0.69) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL4064829 0.66 ADORA2A (1.00) ADORA3ADORA1ADORA2AADORA2BPI4KA
SCHEMBL783764 0.66 ADORA3 (0.68) ADORA3ADORA1ADORA2AADORA2BPI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049491-B1 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF E1 ACTIVATING ENZYMES MILLENNIUM PHARM INC (US) 2010-10-20 EP disclosed